Prevalence of hypertension, female in Late-demographic dividend

Late-demographic dividend: Prevalence of hypertension, female was 29.1% in 2019. ▲ Rising

Latest (2019)
29.1%
Change on year
down 1.1%
Rank
36th
of 43 groups
All-time high
31.8%
in 2009
All-time low
28.6%
in 1990
Years of data
30
1990–2019

Prevalence of hypertension, female in Late-demographic dividend, 1990–2019

01020301990200420191990: 28.6 % of female adults ages 30-791991: 28.8 % of female adults ages 30-791992: 29 % of female adults ages 30-791993: 29.2 % of female adults ages 30-791994: 29.3 % of female adults ages 30-791995: 29.4 % of female adults ages 30-791996: 29.5 % of female adults ages 30-791997: 29.6 % of female adults ages 30-791998: 29.8 % of female adults ages 30-791999: 29.9 % of female adults ages 30-792000: 30.1 % of female adults ages 30-792001: 30.3 % of female adults ages 30-792002: 30.5 % of female adults ages 30-792003: 30.7 % of female adults ages 30-792004: 31 % of female adults ages 30-792005: 31.2 % of female adults ages 30-792006: 31.5 % of female adults ages 30-792007: 31.7 % of female adults ages 30-792008: 31.7 % of female adults ages 30-792009: 31.8 % of female adults ages 30-792010: 31.7 % of female adults ages 30-792011: 31.6 % of female adults ages 30-792012: 31.3 % of female adults ages 30-792013: 30.9 % of female adults ages 30-792014: 30.6 % of female adults ages 30-792015: 30.3 % of female adults ages 30-792016: 30 % of female adults ages 30-792017: 29.7 % of female adults ages 30-792018: 29.4 % of female adults ages 30-792019: 29.1 % of female adults ages 30-79

Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of female adults ages 30-79.

Analysis

In 2019, prevalence of hypertension, female in Late-demographic dividend stood at 29.1%.

The figure is down 1.1% on the previous year and down 8.6% over ten years.

Over the whole period, prevalence of hypertension, female in Late-demographic dividend peaked at 31.8% in 2009 and was at its lowest, 28.6%, in 1990.

That places Late-demographic dividend 36th out of 43 groups with data for 2019, putting it in the bottom quarter.

The long-run direction has been consistently rising across the 30 years of available data.

Prevalence of hypertension, female in Late-demographic dividend, year by year

Annual values for Prevalence of hypertension, female (% of female adults ages 30-79) in Late-demographic dividend, 1990 to 2019.
Year % of female adults ages 30-79 Change
1990 28.6%
1991 28.8% +0.8%
1992 29.0% +0.8%
1993 29.2% +0.4%
1994 29.3% +0.4%
1995 29.4% +0.3%
1996 29.5% +0.4%
1997 29.6% +0.5%
1998 29.8% +0.5%
1999 29.9% +0.5%
2000 30.1% +0.6%
2001 30.3% +0.7%
2002 30.5% +0.7%
2003 30.7% +0.7%
2004 31.0% +0.8%
2005 31.2% +0.8%
2006 31.5% +0.8%
2007 31.7% +0.6%
2008 31.7% +0.2%
2009 31.8% +0.2%
2010 31.7% -0.3%
2011 31.6% -0.5%
2012 31.3% -1.0%
2013 30.9% -1.0%
2014 30.6% -1.0%
2015 30.3% -1.0%
2016 30.0% -1.1%
2017 29.7% -1.1%
2018 29.4% -1.1%
2019 29.1% -1.1%

Averages by decade

DecadeAverage LowestHighest Years
1990s 29.3% 28.6% 29.9% 10
2000s 31.1% 30.1% 31.8% 10
2010s 30.5% 29.1% 31.7% 10

Countries ranked near Late-demographic dividend

  1. 34 Antigua and Barbuda 43.2% compare
  2. 34 Kyrgyzstan 43.2% compare
  3. 34 Puerto Rico 43.2% compare
  4. 37 Bhutan 43.0% compare
  5. 38 Senegal 42.9% compare
  6. 39 Central African Republic 42.8% compare
  7. 39 Tajikistan 42.8% compare

See the full ranking of 235 places →

More health data for Late-demographic dividend

All data for Late-demographic dividend →

Frequently asked questions

What is prevalence of hypertension, female in Late-demographic dividend?
Prevalence of hypertension, female in Late-demographic dividend was 29.1% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
What is the highest prevalence of hypertension, female recorded in Late-demographic dividend?
The highest recorded value was 31.8% in 2009.
What is the lowest prevalence of hypertension, female recorded in Late-demographic dividend?
The lowest recorded value was 28.6% in 1990.
How does Late-demographic dividend rank for prevalence of hypertension, female?
Late-demographic dividend ranks 36th out of 43 groups with data for 2019.
Is prevalence of hypertension, female rising or falling in Late-demographic dividend?
Over the last ten years it is down 8.6%. The long-run trend across the full record is rising.
Where does this Late-demographic dividend data come from?
The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Prevalence of hypertension, female (% of female adults ages 30-79). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Prevalence of hypertension, female in Late-demographic dividend. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 18 September 2026, from https://health.statizoid.com/stat/prevalence-of-hypertension-female-percent-of-female-adults-ages-30-79/late-demographic-dividend/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/prevalence-of-hypertension-female-percent-of-female-adults-ages-30-79/late-demographic-dividend/">Prevalence of hypertension, female in Late-demographic dividend</a> — Statizoid

About this data

Indicator
Prevalence of hypertension, female (% of female adults ages 30-79)
Unit
% of female adults ages 30-79
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Prevalence of hypertension, female, is the percentage of female adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.